News & Events

By immersing ourselves in events and initiative, our expert teams are designed to keep you informed about the latest industry developments. Our goal is to provide essential support and tools for the success of your own groundbreaking projects.
  • / Uncategorized
Curapath Strengthens PEG-Free Delivery Platform Through Exclusive Agreement with Calusa Bio

Curapath has entered into an exclusive license agreement with Calusa Bio, LLC, further strengthening its PEG alternative toolbox with a novel and differentiated technology. This strategic...

Read More
  • / Uncategorized
Curapath and Cayman Chemical Partner to Expand Access to PEG-Free Shielding Lipids for Advanced LNP Formulations

VALENCIA, SPAIN, SEPTEMBER 2, 2025 At Curapath, our mission has always been to push the boundaries of non-viral drug delivery. Today, we are proud to announce...

Read More
  • / Uncategorized
7 Questions with Philippe Clavel: What Matters Most to a CEO Leading Through Transformation

The CDMO journey is never just operational, it’s human. In this 7-question Q&A, Philippe Clavel, CEO of Curapath, shares his reflections on the first half of...

Read More
  • / Uncategorized
Macro Biologics and Curapath Expand Strategic Partnership to Manufacture Advanced Biomaterials for Healthcare and Beyond

VALENCIA, COMUNIDAD VALENCIANA, SPAIN, July 1, 2025 /EINPresswire.com/ — Macro Biologics, Inc. , a US-based company (Carlsbad, Carlifornia) at the intersection of materials science and biotechnology,...

Read More
  • / Uncategorized
Curapath receives representatives of the Valencian Generalitat in their facilities at the Valencia technology park

Paterna, May 9, 2025 – Curapath, a global life sciences company specializing in the custom design, development, and manufacturing of advanced drug delivery systems, yesterday welcomed...

Read More
Club Of The Valencian Community
  • / Uncategorized
Curapath joins The Innovation Club of the Valencian Community and participates in its General Assembly

February 24, 2025, Valencia, Spain – In a significant step towards strengthening its presence in the biotechnology and pharmaceutical sector, CURAPATH has been officially accepted...

Read More
Proyecto cofinanciado por los Fondos FEDER, dentro del Programa Operativo FEDER de la Comunidad Valenciana 2021-2027

Desarrollo de nuevas plataformas de lípidos y su optimización en el uso de nanopartículas lipídicas para el transporte de material genético

PROGRAMA: AYUDAS PARA PROYECTOS DE I+D PYME PIDI-CV Nº Expediente: IMIDTA/2023/73

Proyecto subvencionado por el CDTI y apoyado por el Ministerio de Ciencia e Innovación

Investigación de nueva vacuna para enfermedad respiratoria humana

(VSRVAC)

PROGRAMA: Programa Misiones Empresas

Nº Expediente: EXP 00146282 / MIG-20211034

POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. ha llevado a cabo en el año 2024 un proyecto de inversión importante en sus instalaciones con un importe subvencionado de 110.427,00 € y concedido por la Conselleria de Innovación, Industria, Comercio y Turismo a través del expediente INPYME/2024/947 dentro de la convocatoria de ayudas INPYME 2024 (Ayudas para apoyar las inversiones productivas realizadas por las PYMES de diversos sectores industriales de la Comunitat Valenciana para el ejercicio 2024 (INPYME). Industria)

Contact Us